Circulating tumour cells (CTCs) are cancer cells that escape from primary tumour sites and enter the bloodstream. This metastasis is responsible for the majority of deaths from cancer. Monitoring the level of CTC levels in blood is thus important but has proved difficult to do. A team of researchers in China and the US has now developed a new way to isolate these cells using a technique called size-amplified acoustofluidics in which the CTCs selectively bind to microbeads.
The bound cancer cells are significantly different in terms of size and physical properties (they are stiffer, for example) compared to normal cells, explain the researchers led by Feng Guo of Indiana University in Bloomington in the US. This means that their acoustic radiation force is a 100-fold higher than that of bare CTCs or normal blood cells. They can thus be efficiently sorted from blood using microbeads (the “size-amplifiers”) in a travelling acoustic wave microfluidic device, and then released from the amplifiers by being degraded with enzymes.
The technique is 77% efficient and produces CTCs with a 96% yield.

Image Credit: Huiqin Liu
News This Week
Duke working on developing flu shot using new CoV vaccine technology
Researchers from Duke University are developing a flu shot with the new technology that was used for two coronavirus vaccines. Both the Pfizer-BioNTech and the Moderna shots use part of the virus's genetic code [...]
Long-acting injectable medicine as potential route to COVID-19 therapy
Researchers from the University of Liverpool have shown the potential of repurposing an existing and cheap drug into a long-acting injectable therapy that could be used to treat Covid-19. In a paper published in the journal Nanoscale, [...]
Superbug killer: New nanotech destroys bacteria and fungal cells
Researchers have developed a new superbug-destroying coating that could be used on wound dressings and implants to prevent and treat potentially deadly bacterial and fungal infections. The material is one of the thinnest antimicrobial [...]
US recommends ‘pause’ for J&J vaccine over clot reports
The U.S. is recommending a "pause" in administration of the single-dose Johnson & Johnson COVID-19 vaccine to investigate reports of potentially dangerous blood clots. In a joint statement Tuesday, the Centers for Disease Control [...]
S. African COVID variant better at bypassing Pfizer/BioNTech jab: Israeli study
The South African coronavirus variant is better at "breaking through" the defences of the Pfizer/BioNTech vaccine than other forms of the virus, Israeli experts said Sunday. However, one of the authors told AFP that [...]
Artificial intelligence to explore the biomolecular world
EPFL scientists have developed AI-powered nanosensors that let researchers track various kinds of biological molecules without disturbing them. The tiny world of biomolecules is rich in fascinating interactions between a plethora of different agents [...]
Why SARS-CoV-2 replicates better in the upper respiratory tract
A team of researchers from the Institute for Infectious Diseases (IFIK) at the University of Bern and the Federal Institute of Virology and Immunology (IVI) have assessed virus growth and activation of the cellular [...]
Brown University creates first wireless, implanted brain-computer interface
Researchers at Brown University have succeeded in creating the first wireless, implantable, rechargeable, long-term brain-computer interface. The wireless BCIs have been implanted in pigs and monkeys for over 13 months without issue, and human [...]
Leave A Comment